2025 25138_MCW Pancreatic Cancer Symposium: Tumor Microenvironment in Focus Evaluation

1 Start 2 Complete

Overall Symposium

Please rate the 14th Annual Pancreatic Cancer Symposium on the following:

	Strongly Agree	Agree	Neither Agree nor Disagree	Disagree	Strongly Disagree
Overall, the symposium met my expectations.	Overall, the symposium met my expectations. - Strongly Agree	Overall, the symposium met my expectations. - Agree	Overall, the symposium met my expectations. - Neither Agree nor Disagree	Overall, the symposium met my expectations. - Disagree	Overall, the symposium met my expectations. - Strongly Disagree
The content of the symposium met my expectations.	The content of the symposium met my expectations. - Strongly Agree	The content of the symposium met my expectations. - Agree	The content of the symposium met my expectations. - Neither Agree nor Disagree	The content of the symposium met my expectations. - Disagree	The content of the symposium met my expectations. - Strongly Disagree
The format was conducive to the meeting.	The format was conducive to the meeting. - Strongly Agree	The format was conducive to the meeting. - Agree	The format was conducive to the meeting. - Neither Agree nor Disagree	The format was conducive to the meeting. - Disagree	The format was conducive to the meeting. - Strongly Disagree
The location of the meeting was convenient.	The location of the meeting was convenient. - Strongly Agree	The location of the meeting was convenient. - Agree	The location of the meeting was convenient. - Neither Agree nor Disagree	The location of the meeting was convenient. - Disagree	The location of the meeting was convenient. - Strongly Disagree

Sessions

Please evaluate the content of each of the following sessions/discussions

	Extremely Satisfied	Satisfied	Neither Satisfied nor Dissatisfied	Dissatisfied	Did Not Attend
"Welcome & Introduction" - Douglas B. Evans, MD	"Welcome & Introduction" - Douglas B. Evans, MD - Extremely Satisfied	"Welcome & Introduction" - Douglas B. Evans, MD - Satisfied	"Welcome & Introduction" - Douglas B. Evans, MD - Neither Satisfied nor Dissatisfied	"Welcome & Introduction" - Douglas B. Evans, MD - Dissatisfied	"Welcome & Introduction" - Douglas B. Evans, MD - Did Not Attend
"Imaging the pancreas in 3D to better understand pancreatic cancer initiation" - Ashley Kiemen, PhD	"Imaging the pancreas in 3D to better understand pancreatic cancer initiation" - Ashley Kiemen, PhD - Extremely Satisfied	"Imaging the pancreas in 3D to better understand pancreatic cancer initiation" - Ashley Kiemen, PhD - Satisfied	"Imaging the pancreas in 3D to better understand pancreatic cancer initiation" - Ashley Kiemen, PhD - Neither Satisfied nor Dissatisfied	"Imaging the pancreas in 3D to better understand pancreatic cancer initiation" - Ashley Kiemen, PhD - Dissatisfied	"Imaging the pancreas in 3D to better understand pancreatic cancer initiation" - Ashley Kiemen, PhD - Did Not Attend
"KRAS signaling stoichiometric homeostasis of downstream pathways" - Tommy McFall, PhD	"KRAS signaling stoichiometric homeostasis of downstream pathways" - Tommy McFall, PhD - Extremely Satisfied	"KRAS signaling stoichiometric homeostasis of downstream pathways" - Tommy McFall, PhD - Satisfied	"KRAS signaling stoichiometric homeostasis of downstream pathways" - Tommy McFall, PhD - Neither Satisfied nor Dissatisfied	"KRAS signaling stoichiometric homeostasis of downstream pathways" - Tommy McFall, PhD - Dissatisfied	"KRAS signaling stoichiometric homeostasis of downstream pathways" - Tommy McFall, PhD - Did Not Attend
"Precision Oncology Trials for PDAC at MCW" - Mandana Kamgar, MD, MPH	"Precision Oncology Trials for PDAC at MCW" - Mandana Kamgar, MD, MPH - Extremely Satisfied	"Precision Oncology Trials for PDAC at MCW" - Mandana Kamgar, MD, MPH - Satisfied	"Precision Oncology Trials for PDAC at MCW" - Mandana Kamgar, MD, MPH - Neither Satisfied nor Dissatisfied	"Precision Oncology Trials for PDAC at MCW" - Mandana Kamgar, MD, MPH - Dissatisfied	"Precision Oncology Trials for PDAC at MCW" - Mandana Kamgar, MD, MPH - Did Not Attend
"Comprehensive interrogation of pancreatic cancer tumor immune microenvironment to enable novel treatment strategies" - Venu G. Pillarisetty, MD	"Comprehensive interrogation of pancreatic cancer tumor immune microenvironment to enable novel treatment strategies" - Venu G. Pillarisetty, MD - Extremely Satisfied	"Comprehensive interrogation of pancreatic cancer tumor immune microenvironment to enable novel treatment strategies" - Venu G. Pillarisetty, MD - Satisfied	"Comprehensive interrogation of pancreatic cancer tumor immune microenvironment to enable novel treatment strategies" - Venu G. Pillarisetty, MD - Neither Satisfied nor Dissatisfied	"Comprehensive interrogation of pancreatic cancer tumor immune microenvironment to enable novel treatment strategies" - Venu G. Pillarisetty, MD - Dissatisfied	"Comprehensive interrogation of pancreatic cancer tumor immune microenvironment to enable novel treatment strategies" - Venu G. Pillarisetty, MD - Did Not Attend
"Human tissue based analysis of targeted therapy in PDAC: In silico to bedside" - Nikki Lytle, PhD and Y. David Seo, MD	"Human tissue based analysis of targeted therapy in PDAC: In silico to bedside" - Nikki Lytle, PhD and Y. David Seo, MD - Extremely Satisfied	"Human tissue based analysis of targeted therapy in PDAC: In silico to bedside" - Nikki Lytle, PhD and Y. David Seo, MD - Satisfied	"Human tissue based analysis of targeted therapy in PDAC: In silico to bedside" - Nikki Lytle, PhD and Y. David Seo, MD - Neither Satisfied nor Dissatisfied	"Human tissue based analysis of targeted therapy in PDAC: In silico to bedside" - Nikki Lytle, PhD and Y. David Seo, MD - Dissatisfied	"Human tissue based analysis of targeted therapy in PDAC: In silico to bedside" - Nikki Lytle, PhD and Y. David Seo, MD - Did Not Attend
"Closing Remarks" - Beth Erickson, MD	"Closing Remarks" - Beth Erickson, MD - Extremely Satisfied	"Closing Remarks" - Beth Erickson, MD - Satisfied	"Closing Remarks" - Beth Erickson, MD - Neither Satisfied nor Dissatisfied	"Closing Remarks" - Beth Erickson, MD - Dissatisfied	"Closing Remarks" - Beth Erickson, MD - Did Not Attend

Participation

I attended this symposium for the opportunity to (Check all that apply):

Network with other medical professionals

Continue my own professional development

Present my scientific/academic work

Other: (Please specify)

Participation Other: (Please specify)

Change in Practice

My practice was changed and improved in the following way(s) as a result of the content presented in the course? (Check all that apply)

Diagnostic approach

Therapeutic approach

Disease prevention or health education

System process improvement

No Change

Please check here and explain your choice:

Change in Practice Please check here and explain your choice:

Attend Again

I would attend another MCW Pancreatic Cancer Symposium

Yes

Maybe (Please specify)

Attend Again Maybe (Please specify)

Future Symposium

I think that future symposiums should include:

Commercial Bias

Was the symposium free of commercial bias?

Yes, the content presented was free of commercial bias.

No, there was commercial bias at the symposium. (Please explain)

Commercial Bias No, there was commercial bias at the symposium. (Please explain)

Comments

Please provide any additional comments you may have regarding the symposium:

Leave this field blank

Medical College of Wisconsin

Office of Continuing and Professional Education

2025 25138_MCW Pancreatic Cancer Symposium: Tumor Microenvironment in Focus Evaluation

You are here

2025 25138_MCW Pancreatic Cancer Symposium: Tumor Microenvironment in Focus Evaluation